These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12490114)

  • 1. Study of isolation of fluoroquinolone-resistant Ureaplasma urealyticum and identification of mutant sites.
    Zhang W; Wu Y; Yin W; Yu M
    Chin Med J (Engl); 2002 Oct; 115(10):1573-5. PubMed ID: 12490114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.
    Beeton ML; Chalker VJ; Kotecha S; Spiller OB
    J Antimicrob Chemother; 2009 Sep; 64(3):529-38. PubMed ID: 19567408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients.
    Xie X; Zhang J
    FEMS Microbiol Lett; 2006 Jun; 259(2):181-6. PubMed ID: 16734777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones.
    Piccinelli G; Gargiulo F; Biscaro V; Caccuri F; Caruso A; De Francesco MA
    Infect Genet Evol; 2017 Jan; 47():64-67. PubMed ID: 27884651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
    J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK; Lee YS; Park YK; Kim BS
    Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of five quinolones and analysis of the quinolone resistance-determining regions of gyrA, gyrB, parC, and parE in Ureaplasma parvum and Ureaplasma urealyticum clinical isolates from perinatal patients in Japan.
    Kawai Y; Nakura Y; Wakimoto T; Nomiyama M; Tokuda T; Takayanagi T; Shiraishi J; Wasada K; Kitajima H; Fujita T; Nakayama M; Mitsuda N; Nakanishi I; Takeuchi M; Yanagihara I
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2358-64. PubMed ID: 25645833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro-selected resistance to fluoroquinolones in two Brucella strains associated with mutational changes in gyrA.
    Turkmani A; Psaroulaki A; Christidou A; Chochlakis D; Tabaa D; Tselentis Y
    Int J Antimicrob Agents; 2008 Sep; 32(3):227-32. PubMed ID: 18583100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
    Guo Y; Pei X; Liu X
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
    Billal DS; Fedorko DP; Yan SS; Hotomi M; Fujihara K; Nelson N; Yamanaka N
    J Antimicrob Chemother; 2007 Jan; 59(1):28-34. PubMed ID: 17065188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of mutations in parC and gyrA in forming resistance of Mycoplasma hominis to fluoroquinolones].
    Gushchin AE; Ladygina VG; Govorun VM
    Mol Gen Mikrobiol Virusol; 1999; (4):19-24. PubMed ID: 10621934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.
    Shimada Y; Deguchi T; Nakane K; Masue T; Yasuda M; Yokoi S; Ito S; Nakano M; Ito S; Ishiko H
    Int J Antimicrob Agents; 2010 Sep; 36(3):255-8. PubMed ID: 20580532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the gyrB, parC, and parE genes of quinolone-resistant isolates and mutants of Edwardsiella tarda.
    Kim MS; Jun LJ; Shin SB; Park MA; Jung SH; Kim K; Moon KH; Jeong HD
    J Microbiol Biotechnol; 2010 Dec; 20(12):1735-43. PubMed ID: 21193831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of different Chlamydia-like organisms to quinolones and mutations in the quinoline resistance-determining region of the DNA gyrase A- and topoisomerase-encoding genes.
    Casson N; Greub G
    Int J Antimicrob Agents; 2006 Jun; 27(6):541-4. PubMed ID: 16697560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigating the fluoroquinolone molecular resistant mechanism of Stenotrophomonas maltophilia].
    Tao CM; Lü XJ; Li P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):266-9. PubMed ID: 16608091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
    Yokoi S; Yasuda M; Ito S; Takahashi Y; Ishihara S; Deguchi T; Maeda S; Kubota Y; Tamaki M; Fukushi H
    J Infect Chemother; 2004 Oct; 10(5):262-7. PubMed ID: 16163459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
    Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
    J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
    Chenia HY; Pillay B; Pillay D
    J Antimicrob Chemother; 2006 Dec; 58(6):1274-8. PubMed ID: 17040923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of mutations in Salmonella enterica gyrA, gyrB, parC and parE genes by denaturing high performance liquid chromatography (DHPLC) using standard HPLC instrumentation.
    Randall LP; Coldham NG; Woodward MJ
    J Antimicrob Chemother; 2005 Oct; 56(4):619-23. PubMed ID: 16141278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant-prevention concentrations of enrofloxacin for Escherichia coli isolates from chickens.
    Li Q; Bi X; Diao Y; Deng X
    Am J Vet Res; 2007 Aug; 68(8):812-5. PubMed ID: 17669019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.